Advertisement

An Experimental Approach to Increase Selective Tumour Toxicity of Methotrexate

  • M. H. N. Tattersall

Abstract

Thymidine protects mice bearing leukaemia L1210 and P388 from methotrexate toxicity without impairing antitumour activity. When thymidine containing pellets were implanted subcutaneously in L1210 leukaemia hearing mice, the therapeutic dose range of methotrexate was increased three-fold. The toxic effects of methotrexate in mice may be ascribed to a disturbance of de novo thymidylate synthesis but the antitumour activity must be due to a disturbance of some other folate dependent pathway.

Keywords

Anti Tumour Activity Folinic Acid Antitumour Activity Purine Biosynthesis L1210 Leukaemia 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Djerassi I., “Methotrexate Infusions and Intensive Supportive Care on the Management of Children with Acute Lymphcytic Leukaemia”, follow up report Cancer Res., 27, 2561–2564 (1967).PubMedGoogle Scholar
  2. 2.
    Lefkowitz E., Papac R. C., Bertino J. R., “Head and Neck Cancer III Toxicity of 24 hr Infusions of Methotrexate and Protection by Leucovorin in Patients with Epidermoid Concinoma, Cancer,” Chem. Rep., 51, 305–311 (1967).Google Scholar
  3. 3.
    Goldin A., Venditti J. M., Kline I., Mantel N., “Eradication of Leukaemia Cells (L1210 by Methotrexate and Methotrexate Plus Citrovorum Factor”, Nature, 212, 1548–1550 (1966).PubMedCrossRefGoogle Scholar
  4. 4.
    Levitt M., Mosher M. B., DeConti R. C., Farber L. R., Skeel R.T., Marsh J. C., Mitchell M. S., Papac R. J., Thomas E. D., Bertino J. R., “Improved Therapeutic Index of Methotrexate with Leucovorin Rescue”, Cancer Res., 33, 1729–1734 (1973).PubMedGoogle Scholar
  5. 5.
    Jaffe N., “Recent Advances in the Chemotherapy of Metastatic Osteogenic Sarcoma”, Cancer, 30, 1627–1631 (1972).PubMedCrossRefGoogle Scholar
  6. 6.
    Tattersall M. H. N., Jaffe N., Frei Emil III, “The Pharmacology of Methotrexate Rescue Studies”. The University of Texas, M.D. Anderson Hospital and Tumor Clinic Synposium. The Pharmacologic Basis of Cancer Chemotherapy, Monograph (in press), 1974.Google Scholar
  7. 7.
    Capizzi R. L., Summers W. P., Bertino J. R., “L-Asparaginase Induced Alteration of Amethopterin (Methotrexate) Activity in Mouse Leukaemia L51784”, Annals of the N. Y. Acad, Sci., 186, 302–311 (1971).CrossRefGoogle Scholar
  8. 8.
    Capizzi R. L., Castro O., Aspnes G., “Treatment of Acute Lymphocytic Leukaemia with Intermittent High Dose Methotrexate and Asparaginase”, Proc. Amer. Asso. Cancer Res, 15, 182 (1974).Google Scholar
  9. 9.
    Wahba A. J., Friedkin M., “The enzymatic Synthesis of Thymidylate”, J. Biol. Chem., 237, 3794–3801 (1962).PubMedGoogle Scholar
  10. 10.
    Osborn M. J., Freeman M., Huennekens F. M., “Inhibition of Dihydrofolic Reductase by Aminopterin and Amethopterin”, Proc. Soc. Exp. Biol., 97, 429–429, (1958).PubMedGoogle Scholar
  11. 11.
    Laduron P. “N-Methylation of Dopamine to Epinine in Brain Tissue Using N methyl Tetrahydrofolic Acid as the Methyl Donor”, Nature New Biol., 238, 212–213 (1972).PubMedCrossRefGoogle Scholar
  12. 12.
    Laduron P. M., Gommeren W. R., Leysen J. E., “N-Methylation of Biogenic Amines I”, Biochem. Pharmacol, 23, 1599–1608 (1974). (1974).PubMedCrossRefGoogle Scholar
  13. 13.
    Lajtha L. G. Vane R. J., “Dependence of Bone Marrow Cells on the Liver for Purine Supply”, Nature, 182, 191–192 (1958).PubMedCrossRefGoogle Scholar
  14. 14.
    Killman S-A., “Erythropoietic Response to Thymidine in Pernicious Anaemia”, Acta Medica Scandinavica, 175, 489–496 (1964).CrossRefGoogle Scholar
  15. 15.
    Hughes W. L., Christine M., Stollar B.D., “A Radioimmunoassay for Measurement of Serum Thymidine”, Analyt. Biochem., 55, 468–478 (1973).PubMedCrossRefGoogle Scholar
  16. 16.
    Lee D. J., Prensky W., “Measurements of DNA Turnover: Suppression of IUdR Reutilization in vivo by Long-acting Thymidine Pellets”, Fed. Proc., 31, 6737, (1972).Google Scholar
  17. 17.
    Lazarus H., Oppenheim S. O., Barett E. F., submitted for publication.Google Scholar

Copyright information

© Plenum Press, New York 1976

Authors and Affiliations

  • M. H. N. Tattersall
    • 1
  1. 1.Charing Cross Hospital (Fulham)LondonUK

Personalised recommendations